Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
18
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Guerard Frederic | Director | 9 | $0 | $0 | 2026-10-01 |
| Glicklich Alan | Director | 9 | $0 | $0 | 2026-10-01 |
| Zaytsev Evgeny | Director | 8 | $0 | $0 | 2026-10-01 |
| Shaw Allan | Director | 12 | $0 | $0 | 2026-10-01 |
| WILSON ROBERT N | Director | 32 | $623.2K | $0 | 2026-10-01 |
| Stauderman Kenneth A. | Chief Scientific Officer | 24 | $5.8K | $3.6K | 2026-09-24 |
| Hebbar Sudarshan | Chief Medical Officer | 34 | $169.0K | $0 | 2026-09-24 |
| Bardin Stephen | Chief Financial Officer | 7 | $4.7K | $0 | 2026-09-24 |
| Leheny A. Rachel | Chief Executive Officer | 50 | $164.3K | $0 | 2026-09-24 |
| Roberts Eric W | Chief Business Officer | 87 | $653.4K | $0 | 2026-08-19 |
| ALAFI CAPITAL CO LLC | 10% Owner | 4 | $0 | $0 | 2026-08-19 |
| Middleton Fred A | Director, 10% Owner | 64 | $3.26M | $0 | 2026-06-25 |
| Dunn Michael J. | President and COO | 19 | $0 | $0 | 2025-06-24 |
| Sanderling Venture Partners VI LP | 10% Owner | 23 | $2.93M | $0 | 2024-11-01 |
| BJERKHOLT ERIC | Director | 12 | $6.7K | $0 | 2024-08-27 |
| Geffken Daniel E. | Interim CFO | 3 | $0 | $0 | 2024-05-17 |
| Valence Investments SPV V, LLC | 10% Owner | 5 | $0 | $0 | 2023-03-20 |
| Sanderling Ventures VII, L.P. | 10% Owner | 25 | $0 | $0 | 2023-03-20 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Guerard Frederic | Director | A Award deriv | 2026-10-01 | 2026-10-05 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Glicklich Alan | Director | A Award deriv | 2026-10-01 | 2026-10-05 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Zaytsev Evgeny | Director | A Award deriv | 2026-10-01 | 2026-10-05 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Shaw Allan | Director | A Award deriv | 2026-10-01 | 2026-10-05 | 20,000 | — | $0 | 20,000 | SEC↗ |
| WILSON ROBERT N | Director | A Award deriv | 2026-10-01 | 2026-10-05 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Leheny A. Rachel | CHIEF EXECUTIVE OFFICER | A Award deriv | 2026-09-24 | 2026-09-28 | 360,000 | — | $0 | 360,000 | SEC↗ |
| Bardin Stephen | Chief Financial Officer | A Award deriv | 2026-09-24 | 2026-09-28 | 190,000 | — | $0 | 190,000 | SEC↗ |
| Stauderman Kenneth A. | Chief Scientific Officer | A Award deriv | 2026-09-24 | 2026-09-28 | 180,000 | — | $0 | 180,000 | SEC↗ |
| Hebbar Sudarshan | Chief Medical Officer | A Award deriv | 2026-09-24 | 2026-09-28 | 180,000 | — | $0 | 180,000 | SEC↗ |
| Stauderman Kenneth A. | Chief Scientific Officer | A Award deriv | 2026-09-24 | 2026-09-28 | 180,000 | — | $0 | 180,000 | SEC↗ |
| Hebbar Sudarshan | Chief Medical Officer | A Award deriv | 2026-09-24 | 2026-09-28 | 180,000 | — | $0 | 180,000 | SEC↗ |
| Leheny A. Rachel | CHIEF EXECUTIVE OFFICER, Dir | A Award deriv | 2026-09-24 | 2026-09-28 | 360,000 | — | $0 | 360,000 | SEC↗ |
| Bardin Stephen | Chief Financial Officer | A Award deriv | 2026-09-24 | 2026-09-28 | 190,000 | — | $0 | 190,000 | SEC↗ |
| Leheny A. Rachel | CHIEF EXECUTIVE OFFICER | A Award deriv | 2026-08-19 | 2026-08-21 | 186,729 | — | $0 | 186,729 | SEC↗ |
| Leheny A. Rachel | CHIEF EXECUTIVE OFFICER | A Award deriv | 2026-08-19 | 2026-08-21 | 186,729 | — | $0 | 186,729 | SEC↗ |
| Roberts Eric W | CHIEF BUSINESS OFFICER | A Award deriv | 2026-08-19 | 2026-08-21 | 186,729 | — | $0 | 186,729 | SEC↗ |
| Roberts Eric W | CHIEF BUSINESS OFFICER | A Award deriv | 2026-08-19 | 2026-08-21 | 186,729 | — | $0 | 186,729 | SEC↗ |
| Hebbar Sudarshan | Chief Medical Officer | A Award deriv | 2026-08-19 | 2026-08-21 | 124,486 | — | $0 | 124,486 | SEC↗ |
| Hebbar Sudarshan | Chief Medical Officer | A Award deriv | 2026-08-19 | 2026-08-21 | 124,486 | — | $0 | 124,486 | SEC↗ |
| WILSON ROBERT N | Director | A Award deriv | 2026-08-19 | 2026-08-21 | 1,182,621 | — | $0 | 1,182,621 | SEC↗ |
| WILSON ROBERT N | Director | A Award deriv | 2026-08-19 | 2026-08-21 | 10,000 | — | $0 | 10,000 | SEC↗ |
| WILSON ROBERT N | Director | A Award deriv | 2026-08-19 | 2026-08-21 | 1,182,621 | — | $0 | 1,182,621 | SEC↗ |
| Zaytsev Evgeny | Director | A Award deriv | 2026-08-19 | 2026-08-21 | 1,450,267 | — | $0 | 1,450,267 | SEC↗ |
| Zaytsev Evgeny | Director | A Award deriv | 2026-08-19 | 2026-08-21 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Zaytsev Evgeny | Director | A Award deriv | 2026-08-19 | 2026-08-21 | 1,450,267 | — | $0 | 1,450,267 | SEC↗ |
| Guerard Frederic | Director | A Award deriv | 2026-08-19 | 2026-08-21 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Glicklich Alan | Director | A Award deriv | 2026-08-19 | 2026-08-21 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Shaw Allan | Director | A Award deriv | 2026-08-19 | 2026-08-21 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ALAFI CAPITAL CO LLC | 10% Owner | A Award deriv | 2026-08-19 | 2026-08-24 | 3,529,192 | — | $0 | 3,529,192 | SEC↗ |
| ALAFI CAPITAL CO LLC | 10% Owner | A Award deriv | 2026-08-19 | 2026-08-24 | 3,529,192 | — | $0 | 3,529,192 | SEC↗ |
| Hebbar Sudarshan | Chief Medical Officer | A Award deriv | 2026-08-19 | 2026-08-21 | 124,486 | — | $0 | 124,486 | SEC↗ |
| Hebbar Sudarshan | Chief Medical Officer | A Award deriv | 2026-08-19 | 2026-08-21 | 124,486 | — | $0 | 124,486 | SEC↗ |
| Guerard Frederic | Director | A Award deriv | 2026-08-19 | 2026-08-21 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Glicklich Alan | Director | A Award deriv | 2026-08-19 | 2026-08-21 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Zaytsev Evgeny | Director | A Award deriv | 2026-08-19 | 2026-08-21 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Zaytsev Evgeny | Director | A Award deriv | 2026-08-19 | 2026-08-21 | 1,450,267 | — | $0 | 1,450,267 | SEC↗ |
| Zaytsev Evgeny | Director | A Award deriv | 2026-08-19 | 2026-08-21 | 1,450,267 | — | $0 | 1,450,267 | SEC↗ |
| Shaw Allan | Director | A Award deriv | 2026-08-19 | 2026-08-21 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Roberts Eric W | CHIEF BUSINESS OFFICER, Dire | A Award deriv | 2026-08-19 | 2026-08-21 | 186,729 | — | $0 | 186,729 | SEC↗ |
| Roberts Eric W | CHIEF BUSINESS OFFICER, Dire | A Award deriv | 2026-08-19 | 2026-08-21 | 186,729 | — | $0 | 186,729 | SEC↗ |
| Leheny A. Rachel | CHIEF EXECUTIVE OFFICER, Dir | A Award deriv | 2026-08-19 | 2026-08-21 | 186,729 | — | $0 | 186,729 | SEC↗ |
| Leheny A. Rachel | CHIEF EXECUTIVE OFFICER, Dir | A Award deriv | 2026-08-19 | 2026-08-21 | 186,729 | — | $0 | 186,729 | SEC↗ |
| WILSON ROBERT N | Director | A Award deriv | 2026-08-19 | 2026-08-21 | 10,000 | — | $0 | 10,000 | SEC↗ |
| WILSON ROBERT N | Director | A Award deriv | 2026-08-19 | 2026-08-21 | 1,182,621 | — | $0 | 1,182,621 | SEC↗ |
| WILSON ROBERT N | Director | A Award deriv | 2026-08-19 | 2026-08-21 | 1,182,621 | — | $0 | 1,182,621 | SEC↗ |
| ALAFI CAPITAL CO LLC | 10% Owner | A Award deriv | 2026-08-19 | 2026-08-24 | 3,529,192 | — | $0 | 3,529,192 | SEC↗ |
| ALAFI CAPITAL CO LLC | 10% Owner | A Award deriv | 2026-08-19 | 2026-08-24 | 3,529,192 | — | $0 | 3,529,192 | SEC↗ |
| Zaytsev Evgeny | Director | A Award deriv | 2026-07-02 | 2026-07-07 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Leheny A. Rachel | CHIEF EXECUTIVE OFFICER | A Award | 2026-06-25 | 2026-06-29 | 186,729 | $0.80 | $149.4K | 317,655 | SEC↗ |
| Roberts Eric W | CHIEF BUSINESS OFFICER | A Award | 2026-06-25 | 2026-06-29 | 186,729 | $0.80 | $149.4K | 366,435 | SEC↗ |
| WILSON ROBERT N | Director | A Award | 2026-06-25 | 2026-06-29 | 1,182,621 | $0.80 | $946.1K | 1,604,650 | SEC↗ |
| Hebbar Sudarshan | Chief Medical Officer | A Award | 2026-06-25 | 2026-06-29 | 124,486 | $0.80 | $99.6K | 186,025 | SEC↗ |
| Middleton Fred A | Director, 10% Owner | P Buy | 2026-06-25 | 2026-06-29 | 248,972 | $0.80 | $199.2K | 1,063,272 | SEC↗ |
| Glicklich Alan | Director | A Award deriv | 2025-10-13 | 2025-10-14 | 937 | — | $0 | 937 | SEC↗ |
| Roberts Eric W | CHIEF BUSINESS OFFICER | P Buy | 2025-09-18 | 2025-09-22 | 2,500 | $3.07 | $7.7K | 84,150 | SEC↗ |
| Roberts Eric W | CHIEF BUSINESS OFFICER | P Buy | 2025-09-15 | 2025-09-17 | 3,400 | $2.68 | $9.1K | 81,650 | SEC↗ |
| Roberts Eric W | CHIEF BUSINESS OFFICER | P Buy | 2025-09-12 | 2025-09-15 | 5,000 | $3.12 | $15.6K | 78,250 | SEC↗ |
| Roberts Eric W | CHIEF BUSINESS OFFICER | P Buy | 2025-09-09 | 2025-09-11 | 2,343 | $3.15 | $7.4K | 73,250 | SEC↗ |
| Roberts Eric W | CHIEF BUSINESS OFFICER | P Buy | 2025-08-29 | 2025-09-02 | 800 | $2.74 | $2.2K | 70,907 | SEC↗ |
| Roberts Eric W | CHIEF BUSINESS OFFICER | P Buy | 2025-08-28 | 2025-09-02 | 9,200 | $2.86 | $26.3K | 70,107 | SEC↗ |
| Roberts Eric W | CHIEF BUSINESS OFFICER | P Buy | 2025-08-21 | 2025-08-25 | 3,508 | $2.79 | $9.8K | 60,907 | SEC↗ |
| Roberts Eric W | CHIEF BUSINESS OFFICER | M Exercise deriv | 2025-08-20 | 2025-08-21 | 15,000 | $1.53 | $22.9K | 57,750 | SEC↗ |
| Roberts Eric W | CHIEF BUSINESS OFFICER | P Buy | 2025-08-20 | 2025-08-21 | 2,000 | $2.72 | $5.4K | 57,399 | SEC↗ |
| Roberts Eric W | CHIEF BUSINESS OFFICER | M Exercise | 2025-08-20 | 2025-08-21 | 15,000 | $1.53 | $22.9K | 179,706 | SEC↗ |
| Hebbar Sudarshan | Chief Medical Officer | P Buy | 2025-08-19 | 2025-08-21 | 9,563 | $2.82 | $27.0K | 61,539 | SEC↗ |
| Roberts Eric W | CHIEF BUSINESS OFFICER | P Buy | 2025-08-19 | 2025-08-21 | 1,000 | $2.79 | $2.8K | 55,399 | SEC↗ |
| Hebbar Sudarshan | Chief Medical Officer | P Buy | 2025-08-15 | 2025-08-18 | 4,392 | $2.79 | $12.3K | 51,976 | SEC↗ |
| Roberts Eric W | CHIEF BUSINESS OFFICER | P Buy | 2025-08-15 | 2025-08-19 | 5,076 | $2.90 | $14.7K | 54,399 | SEC↗ |
| Hebbar Sudarshan | Chief Medical Officer | P Buy | 2025-08-14 | 2025-08-18 | 1,584 | $2.59 | $4.1K | 47,584 | SEC↗ |
| Stauderman Kenneth A. | Chief Scientific Officer | P Buy | 2025-07-28 | 2025-07-29 | 1,000 | $3.96 | $4.0K | 12,944 | SEC↗ |
| Stauderman Kenneth A. | Chief Scientific Officer | S Sale | 2025-07-25 | 2025-07-29 | 1,000 | $3.65 | $3.6K | 0 | SEC↗ |
| Roberts Eric W | CHIEF BUSINESS OFFICER | P Buy | 2025-07-22 | 2025-07-23 | 1,500 | $3.78 | $5.7K | 49,323 | SEC↗ |
| Leheny A. Rachel | CHIEF EXECUTIVE OFFICER | P Buy | 2025-07-21 | 2025-07-21 | 1,000 | $3.40 | $3.4K | 3,500 | SEC↗ |
| Roberts Eric W | CHIEF BUSINESS OFFICER | P Buy | 2025-07-21 | 2025-07-22 | 1,500 | $3.37 | $5.1K | 47,823 | SEC↗ |
| Roberts Eric W | CHIEF BUSINESS OFFICER | P Buy | 2025-07-18 | 2025-07-18 | 2,000 | $2.88 | $5.8K | 46,323 | SEC↗ |
| WILSON ROBERT N | Director | P Buy | 2025-07-18 | 2025-07-18 | 4,500 | $2.87 | $12.9K | 422,029 | SEC↗ |
| Leheny A. Rachel | CHIEF EXECUTIVE OFFICER | P Buy | 2025-07-14 | 2025-07-15 | 2,500 | $2.47 | $6.2K | 2,500 | SEC↗ |
| Roberts Eric W | CHIEF BUSINESS OFFICER | P Buy | 2025-07-14 | 2025-07-16 | 6,500 | $2.43 | $15.8K | 44,323 | SEC↗ |
| Roberts Eric W | CHIEF BUSINESS OFFICER | P Buy | 2025-07-09 | 2025-07-10 | 5,000 | $1.60 | $8.0K | 37,823 | SEC↗ |
| Stauderman Kenneth A. | Chief Scientific Officer | P Buy | 2025-07-01 | 2025-07-02 | 1,000 | $1.85 | $1.9K | 1,000 | SEC↗ |
| Bardin Stephen | Chief Financial Officer | P Buy | 2025-06-26 | 2025-06-26 | 2,000 | $1.50 | $3.0K | 3,000 | SEC↗ |
| Roberts Eric W | CHIEF BUSINESS OFFICER | P Buy | 2025-06-26 | 2025-06-27 | 4,500 | $1.44 | $6.5K | 32,823 | SEC↗ |
| MIDDLETON FRED A | Director, 10% Owner | A Award deriv | 2025-06-24 | 2025-06-26 | 10,000 | — | $0 | 10,000 | SEC↗ |
| MIDDLETON FRED A | Director, 10% Owner | A Award deriv | 2025-06-24 | 2025-06-26 | 19,687 | — | $0 | 19,687 | SEC↗ |
| MIDDLETON FRED A | Director, 10% Owner | A Award deriv | 2025-06-24 | 2025-06-26 | 6,562 | — | $0 | 6,562 | SEC↗ |
| MIDDLETON FRED A | Director, 10% Owner | A Award deriv | 2025-06-24 | 2025-06-26 | 10,000 | — | $0 | 10,000 | SEC↗ |
| WILSON ROBERT N | Director | A Award deriv | 2025-06-24 | 2025-06-26 | 36,562 | — | $0 | 36,562 | SEC↗ |
| WILSON ROBERT N | Director | A Award deriv | 2025-06-24 | 2025-06-26 | 12,031 | — | $0 | 12,031 | SEC↗ |
| WILSON ROBERT N | Director | A Award deriv | 2025-06-24 | 2025-06-26 | 10,000 | — | $0 | 10,000 | SEC↗ |
| WILSON ROBERT N | Director | A Award deriv | 2025-06-24 | 2025-06-26 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Shaw Allan | Director | A Award deriv | 2025-06-24 | 2025-06-26 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Shaw Allan | Director | A Award deriv | 2025-06-24 | 2025-06-26 | 8,594 | — | $0 | 8,594 | SEC↗ |
| Shaw Allan | Director | A Award deriv | 2025-06-24 | 2025-06-26 | 26,250 | — | $0 | 26,250 | SEC↗ |
| Shaw Allan | Director | A Award deriv | 2025-06-24 | 2025-06-26 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Glicklich Alan | Director | A Award deriv | 2025-06-24 | 2025-06-26 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Glicklich Alan | Director | A Award deriv | 2025-06-24 | 2025-06-26 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Glicklich Alan | Director | A Award deriv | 2025-06-24 | 2025-06-26 | 4,166 | — | $0 | 4,166 | SEC↗ |
| Glicklich Alan | Director | A Award deriv | 2025-06-24 | 2025-06-26 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Guerard Frederic | Director | A Award deriv | 2025-06-24 | 2025-06-26 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Guerard Frederic | Director | A Award deriv | 2025-06-24 | 2025-06-26 | 5,000 | — | $0 | 5,000 | SEC↗ |
| Guerard Frederic | Director | A Award deriv | 2025-06-24 | 2025-06-26 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Guerard Frederic | Director | A Award deriv | 2025-06-24 | 2025-06-26 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Leheny A. Rachel | CHIEF EXECUTIVE OFFICER | A Award deriv | 2025-06-24 | 2025-06-26 | 77,625 | — | $0 | 77,625 | SEC↗ |
| Dunn Michael J. | President and COO | A Award deriv | 2025-06-24 | 2025-06-26 | 47,125 | — | $0 | 47,125 | SEC↗ |
| Roberts Eric W | CHIEF BUSINESS OFFICER | A Award deriv | 2025-06-24 | 2025-06-26 | 72,750 | — | $0 | 72,750 | SEC↗ |
| Stauderman Kenneth A. | Chief Scientific Officer | A Award deriv | 2025-06-24 | 2025-06-26 | 47,125 | — | $0 | 47,125 | SEC↗ |
| Bardin Stephen | Chief Financial Officer | A Award deriv | 2025-06-24 | 2025-06-26 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Hebbar Sudarshan | Chief Medical Officer | A Award deriv | 2025-06-24 | 2025-06-26 | 83,300 | — | $0 | 83,300 | SEC↗ |
| Roberts Eric W | CHIEF BUSINESS OFFICER | P Buy | 2025-06-11 | 2025-06-13 | 5,000 | $1.85 | $9.3K | 28,323 | SEC↗ |
| Roberts Eric W | CHIEF BUSINESS OFFICER | P Buy | 2025-06-06 | 2025-06-09 | 5,000 | $1.78 | $8.9K | 23,323 | SEC↗ |
| Roberts Eric W | CHIEF BUSINESS OFFICER | P Buy | 2025-06-05 | 2025-06-09 | 5,100 | $1.70 | $8.7K | 18,323 | SEC↗ |
| Bardin Stephen | Chief Financial Officer | P Buy | 2025-05-30 | 2025-06-03 | 1,000 | $1.69 | $1.7K | 41,000 | SEC↗ |
| Leheny A. Rachel | CHIEF EXECUTIVE OFFICER | A Award deriv | 2025-04-23 | 2025-04-25 | 285,000 | — | $0 | 285,000 | SEC↗ |
| Hebbar Sudarshan | Chief Medical Officer | A Award deriv | 2025-04-23 | 2025-04-25 | 175,000 | — | $0 | 175,000 | SEC↗ |
| Roberts Eric W | CHIEF BUSINESS OFFICER | A Award deriv | 2025-04-23 | 2025-04-25 | 160,000 | — | $0 | 160,000 | SEC↗ |
| Dunn Michael J. | President and COO | A Award deriv | 2025-04-23 | 2025-04-25 | 125,000 | — | $0 | 125,000 | SEC↗ |
| Stauderman Kenneth A. | Chief Scientific Officer | A Award deriv | 2025-04-23 | 2025-04-25 | 125,000 | — | $0 | 125,000 | SEC↗ |
| Bardin Stephen | Chief Financial Officer | A Award deriv | 2025-04-23 | 2025-04-25 | 130,000 | — | $0 | 130,000 | SEC↗ |
| Leheny A. Rachel | CHIEF EXECUTIVE OFFICER | A Award deriv | 2025-04-05 | 2026-04-07 | 148,482 | — | $0 | 148,482 | SEC↗ |
| Stauderman Kenneth A. | Chief Scientific Officer | A Award deriv | 2025-04-05 | 2026-04-07 | 65,124 | — | $0 | 65,124 | SEC↗ |
| Dunn Michael J. | President and COO | A Award deriv | 2025-04-05 | 2026-04-07 | 65,124 | — | $0 | 65,124 | SEC↗ |
| Roberts Eric W | CHIEF BUSINESS OFFICER | A Award deriv | 2025-04-05 | 2026-04-07 | 83,358 | — | $0 | 83,358 | SEC↗ |
| Hebbar Sudarshan | Chief Medical Officer | A Award deriv | 2025-04-05 | 2026-04-07 | 91,173 | — | $0 | 91,173 | SEC↗ |
| Bardin Stephen | Chief Financial Officer | A Award deriv | 2025-04-05 | 2026-04-07 | 67,728 | — | $0 | 67,728 | SEC↗ |
| Glicklich Alan | Director | A Award deriv | 2025-01-15 | 2025-01-16 | 20,000 | — | $0 | 20,000 | SEC↗ |
| MIDDLETON FRED A | Director, 10% Owner | P Buy | 2024-12-06 | 2024-12-06 | 4,800 | $2.65 | $12.7K | 36,514 | SEC↗ |
| WILSON ROBERT N | Director | P Buy | 2024-11-01 | 2024-11-01 | 53,333 | $3.75 | $200.0K | 417,529 | SEC↗ |
| Roberts Eric W | CHIEF BUSINESS OFFICER | P Buy | 2024-11-01 | 2024-11-01 | 53,333 | $3.75 | $200.0K | 164,706 | SEC↗ |
| Leheny A. Rachel | CHIEF EXECUTIVE OFFICER | P Buy | 2024-11-01 | 2024-11-01 | 20,000 | $3.75 | $75.0K | 130,926 | SEC↗ |
| MIDDLETON FRED A | Director, 10% Owner | P Buy | 2024-11-01 | 2024-11-05 | 877 | $3.75 | $3.3K | 22,479 | SEC↗ |
| MIDDLETON FRED A | Director, 10% Owner | P Buy | 2024-11-01 | 2024-11-05 | 86,867 | $3.75 | $325.8K | 814,300 | SEC↗ |
| MIDDLETON FRED A | Director, 10% Owner | P Buy | 2024-11-01 | 2024-11-05 | 20,000 | $3.75 | $75.0K | 31,714 | SEC↗ |
| Sanderling Venture Partners VI | 10% Owner | P Buy | 2024-11-01 | 2024-11-05 | 86,867 | $3.75 | $325.8K | 814,300 | SEC↗ |
| Sanderling Venture Partners VI | 10% Owner | P Buy | 2024-11-01 | 2024-11-05 | 877 | $3.75 | $3.3K | 22,479 | SEC↗ |
| Dunn Michael J. | President and COO | M Exercise deriv | 2024-09-09 | 2024-09-11 | 11,761 | — | $0 | 0 | SEC↗ |
| Dunn Michael J. | President and COO | M Exercise | 2024-09-09 | 2024-09-11 | 11,761 | $1.39 | $16.3K | 11,761 | SEC↗ |
| Leheny A. Rachel | CHIEF EXECUTIVE OFFICER | A Award deriv | 2024-08-27 | 2024-08-28 | 115,000 | — | $0 | 115,000 | SEC↗ |
| Hebbar Sudarshan | Chief Medical Officer | A Award deriv | 2024-08-27 | 2024-08-28 | 82,500 | — | $0 | 82,500 | SEC↗ |
| Roberts Eric W | CHIEF BUSINESS OFFICER | A Award deriv | 2024-08-27 | 2024-08-28 | 77,500 | — | $0 | 77,500 | SEC↗ |
| Stauderman Kenneth A. | Chief Scientific Officer | A Award deriv | 2024-08-27 | 2024-08-28 | 62,500 | — | $0 | 62,500 | SEC↗ |
| Dunn Michael J. | President and COO | A Award deriv | 2024-08-27 | 2024-08-28 | 62,500 | — | $0 | 62,500 | SEC↗ |
| WILSON ROBERT N | Director | A Award deriv | 2024-08-27 | 2024-08-28 | 10,000 | — | $0 | 10,000 | SEC↗ |
| MIDDLETON FRED A | Director, 10% Owner | A Award deriv | 2024-08-27 | 2024-08-28 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Shaw Allan | Director | A Award deriv | 2024-08-27 | 2024-08-28 | 10,000 | — | $0 | 10,000 | SEC↗ |
| BJERKHOLT ERIC | Director | A Award deriv | 2024-08-27 | 2024-08-28 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Guerard Frederic | Director | A Award deriv | 2024-08-27 | 2024-08-28 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Leheny A. Rachel | CHIEF EXECUTIVE OFFICER | P Buy | 2024-08-27 | 2024-08-27 | 1,000 | $4.19 | $4.2K | 110,926 | SEC↗ |
| WILSON ROBERT N | Director | P Buy | 2024-08-23 | 2024-08-26 | 54,000 | $3.72 | $200.9K | 364,196 | SEC↗ |
| Roberts Eric W | CHIEF BUSINESS OFFICER | P Buy | 2024-08-23 | 2024-08-26 | 3,000 | $3.57 | $10.7K | 13,223 | SEC↗ |
| Roberts Eric W | CHIEF BUSINESS OFFICER | P Buy | 2024-08-23 | 2024-08-26 | 2,000 | $3.58 | $7.2K | 46,894 | SEC↗ |
| Roberts Eric W | CHIEF BUSINESS OFFICER | P Buy | 2024-08-21 | 2024-08-22 | 5,000 | $4.04 | $20.2K | 44,894 | SEC↗ |
| WILSON ROBERT N | Director | P Buy | 2024-06-28 | 2024-07-02 | 51,278 | $3.52 | $180.5K | 310,196 | SEC↗ |
| WILSON ROBERT N | Director | P Buy | 2024-06-27 | 2024-07-01 | 8,443 | $3.23 | $27.3K | 258,918 | SEC↗ |
| Roberts Eric W | CHIEF BUSINESS OFFICER | P Buy | 2024-06-27 | 2024-06-28 | 5,000 | $3.22 | $16.1K | 10,223 | SEC↗ |
| Geffken Daniel E. | Interim CFO | A Award deriv | 2024-05-17 | 2024-05-20 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Roberts Eric W | CHIEF BUSINESS OFFICER | P Buy | 2024-04-02 | 2024-04-02 | 3,254 | $3.90 | $12.7K | 39,894 | SEC↗ |
| Roberts Eric W | CHIEF BUSINESS OFFICER | P Buy | 2024-04-01 | 2024-04-02 | 746 | $3.90 | $2.9K | 36,640 | SEC↗ |
| Leheny A. Rachel | CHIEF EXECUTIVE OFFICER | A Award deriv | 2024-03-28 | 2024-04-22 | 115,000 | — | $0 | 115,000 | SEC↗ |
| Hebbar Sudarshan | Chief Medical Officer | A Award deriv | 2024-03-28 | 2024-04-22 | 82,500 | — | $0 | 82,500 | SEC↗ |
| Roberts Eric W | CHIEF BUSINESS OFFICER | A Award deriv | 2024-03-28 | 2024-04-22 | 77,500 | — | $0 | 77,500 | SEC↗ |
| Stauderman Kenneth A. | Chief Scientific Officer | A Award deriv | 2024-03-28 | 2024-04-22 | 62,500 | — | $0 | 62,500 | SEC↗ |
| Dunn Michael J. | President and COO | A Award deriv | 2024-03-28 | 2024-04-22 | 62,500 | — | $0 | 62,500 | SEC↗ |
| WILSON ROBERT N | Director | A Award deriv | 2024-03-28 | 2024-04-22 | 10,000 | — | $0 | 10,000 | SEC↗ |
| MIDDLETON FRED A | Director, 10% Owner | A Award deriv | 2024-03-28 | 2024-04-22 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Shaw Allan | Director | A Award deriv | 2024-03-28 | 2024-04-22 | 10,000 | — | $0 | 10,000 | SEC↗ |
| BJERKHOLT ERIC | Director | A Award deriv | 2024-03-28 | 2024-04-22 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Guerard Frederic | Director | A Award deriv | 2024-03-28 | 2024-04-22 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Roberts Eric W | CHIEF BUSINESS OFFICER | A Award deriv | 2024-02-05 | 2024-02-06 | 45,543 | $0.13 | $5.9K | 45,543 | SEC↗ |
| Roberts Eric W | CHIEF BUSINESS OFFICER | A Award deriv | 2024-02-05 | 2024-02-06 | 45,543 | $0.13 | $5.9K | 45,543 | SEC↗ |
| Roberts Eric W | CHIEF BUSINESS OFFICER | A Award | 2024-02-05 | 2024-02-06 | 91,086 | $4.27 | $388.9K | 111,373 | SEC↗ |
| WILSON ROBERT N | Director | A Award deriv | 2024-01-23 | 2024-01-25 | 34,157 | $0.13 | $4.4K | 34,157 | SEC↗ |
| WILSON ROBERT N | Director | A Award deriv | 2024-01-23 | 2024-01-25 | 34,157 | $0.13 | $4.4K | 34,157 | SEC↗ |
| Leheny A. Rachel | CHIEF EXECUTIVE OFFICER | A Award deriv | 2024-01-23 | 2024-01-25 | 45,543 | $0.13 | $5.9K | 45,543 | SEC↗ |
| Leheny A. Rachel | CHIEF EXECUTIVE OFFICER | A Award deriv | 2024-01-23 | 2024-01-25 | 45,543 | $0.13 | $5.9K | 45,543 | SEC↗ |
| Sanderling Venture Partners VI | 10% Owner | P Buy deriv | 2024-01-23 | 2024-01-25 | 97,236 | $0.13 | $12.6K | 97,236 | SEC↗ |
| Sanderling Venture Partners VI | 10% Owner | P Buy deriv | 2024-01-23 | 2024-01-25 | 97,236 | $0.13 | $12.6K | 97,236 | SEC↗ |
| Sanderling Venture Partners VI | 10% Owner | P Buy deriv | 2024-01-23 | 2024-01-25 | 72,338 | $0.13 | $9.4K | 72,338 | SEC↗ |
| Sanderling Venture Partners VI | 10% Owner | P Buy deriv | 2024-01-23 | 2024-01-25 | 6,592 | $0.13 | $857 | 6,592 | SEC↗ |
| Sanderling Venture Partners VI | 10% Owner | P Buy deriv | 2024-01-23 | 2024-01-25 | 6,592 | $0.13 | $857 | 6,592 | SEC↗ |
| Sanderling Venture Partners VI | 10% Owner | P Buy deriv | 2024-01-23 | 2024-01-25 | 1,960 | $0.13 | $255 | 1,960 | SEC↗ |
| Sanderling Venture Partners VI | 10% Owner | P Buy deriv | 2024-01-23 | 2024-01-25 | 1,960 | $0.13 | $255 | 1,960 | SEC↗ |
| Sanderling Venture Partners VI | 10% Owner | P Buy deriv | 2024-01-23 | 2024-01-25 | 14,372 | $0.13 | $1.9K | 14,372 | SEC↗ |
| Sanderling Venture Partners VI | 10% Owner | P Buy deriv | 2024-01-23 | 2024-01-25 | 14,372 | $0.13 | $1.9K | 14,372 | SEC↗ |
| Sanderling Venture Partners VI | 10% Owner | P Buy deriv | 2024-01-23 | 2024-01-25 | 72,338 | $0.13 | $9.4K | 72,338 | SEC↗ |
| Sanderling Venture Partners VI | 10% Owner | P Buy deriv | 2024-01-23 | 2024-01-25 | 25,516 | $0.13 | $3.3K | 25,516 | SEC↗ |
| Sanderling Venture Partners VI | 10% Owner | P Buy deriv | 2024-01-23 | 2024-01-25 | 121,678 | $0.13 | $15.8K | 121,678 | SEC↗ |
| Sanderling Venture Partners VI | 10% Owner | P Buy deriv | 2024-01-23 | 2024-01-25 | 25,516 | $0.13 | $3.3K | 25,516 | SEC↗ |
| Sanderling Venture Partners VI | 10% Owner | P Buy deriv | 2024-01-23 | 2024-01-25 | 121,678 | $0.13 | $15.8K | 121,678 | SEC↗ |
| MIDDLETON FRED A | Director, 10% Owner | P Buy deriv | 2024-01-23 | 2024-01-25 | 121,678 | $0.13 | $15.8K | 121,678 | SEC↗ |
| MIDDLETON FRED A | Director, 10% Owner | P Buy deriv | 2024-01-23 | 2024-01-25 | 121,678 | $0.13 | $15.8K | 121,678 | SEC↗ |
| MIDDLETON FRED A | Director, 10% Owner | P Buy deriv | 2024-01-23 | 2024-01-25 | 72,338 | $0.13 | $9.4K | 72,338 | SEC↗ |
| MIDDLETON FRED A | Director, 10% Owner | P Buy deriv | 2024-01-23 | 2024-01-25 | 97,236 | $0.13 | $12.6K | 97,236 | SEC↗ |
| MIDDLETON FRED A | Director, 10% Owner | P Buy deriv | 2024-01-23 | 2024-01-25 | 97,236 | $0.13 | $12.6K | 97,236 | SEC↗ |
| MIDDLETON FRED A | Director, 10% Owner | P Buy deriv | 2024-01-23 | 2024-01-25 | 25,516 | $0.13 | $3.3K | 25,516 | SEC↗ |
| MIDDLETON FRED A | Director, 10% Owner | P Buy deriv | 2024-01-23 | 2024-01-25 | 25,516 | $0.13 | $3.3K | 25,516 | SEC↗ |
| MIDDLETON FRED A | Director, 10% Owner | P Buy deriv | 2024-01-23 | 2024-01-25 | 6,592 | $0.13 | $857 | 6,592 | SEC↗ |
| MIDDLETON FRED A | Director, 10% Owner | P Buy deriv | 2024-01-23 | 2024-01-25 | 6,592 | $0.13 | $857 | 6,592 | SEC↗ |
| MIDDLETON FRED A | Director, 10% Owner | P Buy deriv | 2024-01-23 | 2024-01-25 | 1,960 | $0.13 | $255 | 1,960 | SEC↗ |
| MIDDLETON FRED A | Director, 10% Owner | P Buy deriv | 2024-01-23 | 2024-01-25 | 1,960 | $0.13 | $255 | 1,960 | SEC↗ |
| MIDDLETON FRED A | Director, 10% Owner | P Buy deriv | 2024-01-23 | 2024-01-25 | 14,372 | $0.13 | $1.9K | 14,372 | SEC↗ |
| MIDDLETON FRED A | Director, 10% Owner | P Buy deriv | 2024-01-23 | 2024-01-25 | 14,372 | $0.13 | $1.9K | 14,372 | SEC↗ |
| MIDDLETON FRED A | Director, 10% Owner | P Buy deriv | 2024-01-23 | 2024-01-25 | 72,338 | $0.13 | $9.4K | 72,338 | SEC↗ |
| WILSON ROBERT N | Director | A Award | 2024-01-23 | 2024-01-25 | 68,314 | $4.27 | $291.7K | 250,475 | SEC↗ |
| Leheny A. Rachel | CHIEF EXECUTIVE OFFICER | A Award | 2024-01-23 | 2024-01-25 | 91,086 | $4.27 | $388.9K | 109,926 | SEC↗ |
| Sanderling Venture Partners VI | 10% Owner | P Buy | 2024-01-23 | 2024-01-25 | 144,676 | $3.70 | $535.3K | 727,433 | SEC↗ |
| Sanderling Venture Partners VI | 10% Owner | P Buy | 2024-01-23 | 2024-01-25 | 243,356 | $3.70 | $900.4K | 946,744 | SEC↗ |
| Sanderling Venture Partners VI | 10% Owner | P Buy | 2024-01-23 | 2024-01-25 | 194,472 | $3.70 | $719.5K | 435,148 | SEC↗ |
| Sanderling Venture Partners VI | 10% Owner | P Buy | 2024-01-23 | 2024-01-25 | 51,032 | $3.70 | $188.8K | 114,260 | SEC↗ |
| Sanderling Venture Partners VI | 10% Owner | P Buy | 2024-01-23 | 2024-01-25 | 13,184 | $3.70 | $48.8K | 27,609 | SEC↗ |
| Sanderling Venture Partners VI | 10% Owner | P Buy | 2024-01-23 | 2024-01-25 | 3,920 | $3.70 | $14.5K | 21,602 | SEC↗ |
| Sanderling Venture Partners VI | 10% Owner | P Buy | 2024-01-23 | 2024-01-25 | 28,744 | $3.70 | $106.4K | 30,292 | SEC↗ |
| MIDDLETON FRED A | Director, 10% Owner | P Buy | 2024-01-23 | 2024-01-25 | 28,744 | $3.70 | $106.4K | 30,292 | SEC↗ |
| MIDDLETON FRED A | Director, 10% Owner | P Buy | 2024-01-23 | 2024-01-25 | 51,032 | $3.70 | $188.8K | 114,260 | SEC↗ |
| MIDDLETON FRED A | Director, 10% Owner | P Buy | 2024-01-23 | 2024-01-25 | 243,356 | $3.70 | $900.4K | 946,744 | SEC↗ |
| MIDDLETON FRED A | Director, 10% Owner | P Buy | 2024-01-23 | 2024-01-25 | 3,920 | $3.70 | $14.5K | 21,602 | SEC↗ |
| MIDDLETON FRED A | Director, 10% Owner | P Buy | 2024-01-23 | 2024-01-25 | 13,184 | $3.70 | $48.8K | 27,609 | SEC↗ |
| MIDDLETON FRED A | Director, 10% Owner | P Buy | 2024-01-23 | 2024-01-25 | 194,472 | $3.70 | $719.5K | 435,148 | SEC↗ |
| MIDDLETON FRED A | Director, 10% Owner | P Buy | 2024-01-23 | 2024-01-25 | 144,676 | $3.70 | $535.3K | 727,433 | SEC↗ |
| WILSON ROBERT N | Director | P Buy | 2023-12-11 | 2023-12-13 | 506 | $3.30 | $1.7K | 182,161 | SEC↗ |
| Leheny A. Rachel | Chief Executive Officer | P Buy | 2023-11-07 | 2023-11-08 | 2,000 | $3.34 | $6.7K | 18,840 | SEC↗ |
| Leheny A. Rachel | Chief Executive Officer | P Buy | 2023-11-06 | 2023-11-07 | 2,440 | $3.12 | $7.6K | 16,840 | SEC↗ |
| Roberts Eric W | Chief Business Officer | P Buy | 2023-11-06 | 2023-11-08 | 2,400 | $3.12 | $7.5K | 35,894 | SEC↗ |
| Leheny A. Rachel | Chief Executive Officer | P Buy | 2023-11-03 | 2023-11-06 | 5,000 | $2.85 | $14.3K | 14,400 | SEC↗ |
| Roberts Eric W | Chief Business Officer | P Buy | 2023-11-03 | 2023-11-06 | 5,860 | $2.70 | $15.8K | 22,245 | SEC↗ |
| Roberts Eric W | Chief Business Officer | P Buy | 2023-11-03 | 2023-11-06 | 3,200 | $2.80 | $9.0K | 16,587 | SEC↗ |
| Hebbar Sudarshan | Chief Medical Officer | P Buy | 2023-11-03 | 2023-11-07 | 36,000 | $2.74 | $98.6K | 46,000 | SEC↗ |
| Roberts Eric W | Chief Business Officer | P Buy | 2023-11-03 | 2023-11-07 | 11,249 | $2.83 | $31.8K | 33,494 | SEC↗ |
| Roberts Eric W | Chief Business Officer | P Buy | 2023-11-03 | 2023-11-07 | 3,700 | $2.77 | $10.2K | 20,287 | SEC↗ |
| Roberts Eric W | Chief Business Officer | P Buy | 2023-08-29 | 2023-09-05 | 223 | $3.02 | $673 | 5,223 | SEC↗ |
| Roberts Eric W | Chief Business Officer | P Buy | 2023-08-25 | 2023-08-29 | 736 | $3.18 | $2.3K | 5,000 | SEC↗ |
| Roberts Eric W | Chief Business Officer | P Buy | 2023-08-22 | 2023-08-23 | 714 | $3.27 | $2.3K | 4,264 | SEC↗ |
| Roberts Eric W | Chief Business Officer | P Buy | 2023-08-21 | 2023-08-23 | 1,750 | $3.25 | $5.7K | 3,550 | SEC↗ |
| Roberts Eric W | Chief Business Officer | P Buy | 2023-06-26 | 2023-06-26 | 200 | $3.53 | $706 | 16,385 | SEC↗ |
| Roberts Eric W | Chief Business Officer | P Buy | 2023-06-26 | 2023-06-26 | 1,200 | $3.70 | $4.4K | 13,387 | SEC↗ |
| Roberts Eric W | Chief Business Officer | P Buy | 2023-06-23 | 2023-06-26 | 500 | $3.35 | $1.7K | 16,185 | SEC↗ |
| Roberts Eric W | Chief Business Officer | P Buy | 2023-06-21 | 2023-06-22 | 2,000 | $4.13 | $8.3K | 15,685 | SEC↗ |
| Roberts Eric W | Chief Business Officer | P Buy | 2023-06-20 | 2023-06-22 | 500 | $4.85 | $2.4K | 13,685 | SEC↗ |
| Leheny A. Rachel | Chief Executive Officer | P Buy | 2023-06-09 | 2023-06-09 | 400 | $5.25 | $2.1K | 9,328 | SEC↗ |
| MIDDLETON FRED A | Director, 10% Owner | P Buy | 2023-06-09 | 2023-06-09 | 714 | $5.20 | $3.7K | 11,714 | SEC↗ |
| Leheny A. Rachel | Chief Executive Officer | P Buy | 2023-06-08 | 2023-06-09 | 928 | $5.23 | $4.9K | 8,928 | SEC↗ |
| Roberts Eric W | Chief Business Officer | P Buy | 2023-06-08 | 2023-06-09 | 485 | $5.20 | $2.5K | 13,185 | SEC↗ |
| Leheny A. Rachel | Chief Executive Officer | P Buy | 2023-06-08 | 2023-06-15 | 1,000 | $5.23 | $5.2K | 9,000 | SEC↗ |
| Leheny A. Rachel | Chief Executive Officer | P Buy | 2023-06-07 | 2023-06-08 | 1,000 | $5.25 | $5.3K | 8,000 | SEC↗ |
| Roberts Eric W | Chief Business Officer | P Buy | 2023-06-07 | 2023-06-08 | 1,500 | $5.23 | $7.8K | 12,700 | SEC↗ |
| MIDDLETON FRED A | Director, 10% Owner | P Buy | 2023-06-07 | 2023-06-08 | 500 | $5.20 | $2.6K | 11,000 | SEC↗ |
| Leheny A. Rachel | Chief Executive Officer | P Buy | 2023-06-06 | 2023-06-08 | 1,000 | $5.13 | $5.1K | 7,000 | SEC↗ |
| Roberts Eric W | Chief Business Officer | P Buy | 2023-06-06 | 2023-06-08 | 3,200 | $5.09 | $16.3K | 11,200 | SEC↗ |
| MIDDLETON FRED A | Director, 10% Owner | P Buy | 2023-06-06 | 2023-06-08 | 500 | $4.88 | $2.4K | 10,500 | SEC↗ |
| Roberts Eric W | Chief Business Officer | P Buy | 2023-06-02 | 2023-06-05 | 1,687 | $4.90 | $8.3K | 12,187 | SEC↗ |
| Leheny A. Rachel | Chief Executive Officer | P Buy | 2023-06-02 | 2023-06-05 | 1,000 | $4.80 | $4.8K | 6,000 | SEC↗ |
| Roberts Eric W | Chief Business Officer | P Buy | 2023-06-01 | 2023-06-05 | 2,000 | $4.42 | $8.8K | 10,500 | SEC↗ |
| BJERKHOLT ERIC | Director | P Buy | 2023-05-31 | 2023-06-01 | 150 | $4.20 | $630 | 3,684 | SEC↗ |
| BJERKHOLT ERIC | Director | P Buy | 2023-05-31 | 2023-06-01 | 100 | $4.09 | $409 | 3,534 | SEC↗ |
| Leheny A. Rachel | Chief Executive Officer | P Buy | 2023-05-31 | 2023-06-01 | 1,000 | $4.21 | $4.2K | 5,000 | SEC↗ |
| Roberts Eric W | Chief Business Officer | P Buy | 2023-05-30 | 2023-06-01 | 2,000 | $3.86 | $7.7K | 8,000 | SEC↗ |
| BJERKHOLT ERIC | Director | P Buy | 2023-05-30 | 2023-06-01 | 5 | $3.25 | $16 | 3,434 | SEC↗ |
| Roberts Eric W | Chief Business Officer | P Buy | 2023-05-23 | 2023-05-24 | 2,000 | $3.26 | $6.5K | 8,500 | SEC↗ |
| Leheny A. Rachel | Chief Executive Officer | P Buy | 2023-05-23 | 2023-05-24 | 3,000 | $3.34 | $10.0K | 4,000 | SEC↗ |
| BJERKHOLT ERIC | Director | P Buy | 2023-05-23 | 2023-05-24 | 500 | $3.27 | $1.6K | 3,429 | SEC↗ |
| Roberts Eric W | Chief Business Officer | P Buy | 2023-05-22 | 2023-05-24 | 6,000 | $2.95 | $17.7K | 6,000 | SEC↗ |
| MIDDLETON FRED A | Director, 10% Owner | P Buy | 2023-05-19 | 2023-05-22 | 10,000 | $2.85 | $28.5K | 10,000 | SEC↗ |
| BJERKHOLT ERIC | Director | P Buy | 2023-05-19 | 2023-05-22 | 199 | $2.65 | $527 | 2,929 | SEC↗ |
| BJERKHOLT ERIC | Director | P Buy | 2023-05-18 | 2023-05-18 | 300 | $2.70 | $810 | 2,729 | SEC↗ |
| BJERKHOLT ERIC | Director | P Buy | 2023-05-18 | 2023-05-22 | 1 | $2.65 | $3 | 2,730 | SEC↗ |
| Roberts Eric W | CHIEF BUSINESS OFFICER | P Buy | 2023-05-17 | 2024-11-06 | 3,000 | $2.68 | $8.0K | 3,000 | SEC↗ |
| Roberts Eric W | Chief Business Officer | P Buy | 2023-05-17 | 2023-05-18 | 3,000 | $2.68 | $8.0K | 6,500 | SEC↗ |
| BJERKHOLT ERIC | Director | P Buy | 2023-05-17 | 2023-05-18 | 200 | $2.67 | $534 | 2,429 | SEC↗ |
| Leheny A. Rachel | Chief Executive Officer | P Buy | 2023-05-16 | 2023-05-18 | 1,000 | $2.69 | $2.7K | 1,000 | SEC↗ |
| Roberts Eric W | Chief Business Officer | P Buy | 2023-05-16 | 2023-05-18 | 1,800 | $2.72 | $4.9K | 1,800 | SEC↗ |
| Roberts Eric W | Chief Business Officer | P Buy | 2023-05-16 | 2023-05-18 | 3,500 | $2.71 | $9.5K | 3,500 | SEC↗ |
| Hebbar Sudarshan | Chief Medical Officer | P Buy | 2023-05-16 | 2023-05-18 | 10,000 | $2.70 | $27.0K | 10,000 | SEC↗ |
| BJERKHOLT ERIC | Director | P Buy | 2023-05-16 | 2023-05-18 | 800 | $2.70 | $2.2K | 2,229 | SEC↗ |
| Leheny A. Rachel | Chief Executive Officer | P Buy | 2023-05-16 | 2023-06-05 | 1,000 | $2.70 | $2.7K | 1,000 | SEC↗ |
| Leheny A. Rachel | Chief Executive Officer | A Award deriv | 2023-05-08 | 2023-05-10 | 110,380 | — | $0 | 110,380 | SEC↗ |
| Stauderman Kenneth A. | Chief Scientific Officer | A Award deriv | 2023-05-08 | 2023-05-10 | 68,988 | — | $0 | 68,988 | SEC↗ |
| Dunn Michael J. | President and COO | A Award deriv | 2023-05-08 | 2023-05-10 | 55,190 | — | $0 | 55,190 | SEC↗ |
| Hebbar Sudarshan | Chief Medical Officer | A Award deriv | 2023-05-08 | 2023-05-10 | 60,709 | — | $0 | 60,709 | SEC↗ |
| Roberts Eric W | Chief Business Officer | A Award deriv | 2023-05-08 | 2023-05-10 | 60,709 | — | $0 | 60,709 | SEC↗ |
| BJERKHOLT ERIC | Director | A Award deriv | 2023-05-08 | 2023-06-28 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Shaw Allan | Director | A Award deriv | 2023-05-08 | 2023-06-28 | 20,000 | — | $0 | 20,000 | SEC↗ |
| MIDDLETON FRED A | Director, 10% Owner | A Award deriv | 2023-05-08 | 2023-06-28 | 20,000 | — | $0 | 20,000 | SEC↗ |
| WILSON ROBERT N | Director | A Award deriv | 2023-05-08 | 2023-06-28 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Sanderling Ventures VII, L.P. | 10% Owner | A Award deriv | 2023-03-20 | 2023-10-10 | 8,393 | — | $0 | 8,393 | SEC↗ |
| Sanderling Ventures VII, L.P. | 10% Owner | A Award deriv | 2023-03-20 | 2023-10-10 | 12,380 | — | $0 | 12,380 | SEC↗ |
| Sanderling Ventures VII, L.P. | 10% Owner | A Award deriv | 2023-03-20 | 2023-10-10 | 2,203 | — | $0 | 2,203 | SEC↗ |
| Sanderling Ventures VII, L.P. | 10% Owner | A Award deriv | 2023-03-20 | 2023-10-10 | 3,249 | — | $0 | 3,249 | SEC↗ |
| Sanderling Ventures VII, L.P. | 10% Owner | A Award deriv | 2023-03-20 | 2023-10-10 | 569 | — | $0 | 569 | SEC↗ |
| Sanderling Ventures VII, L.P. | 10% Owner | A Award deriv | 2023-03-20 | 2023-10-10 | 840 | — | $0 | 840 | SEC↗ |
| Sanderling Ventures VII, L.P. | 10% Owner | A Award deriv | 2023-03-20 | 2023-10-10 | 113 | — | $0 | 113 | SEC↗ |
| Sanderling Ventures VII, L.P. | 10% Owner | A Award deriv | 2023-03-20 | 2023-10-10 | 167 | — | $0 | 167 | SEC↗ |
| Sanderling Ventures VII, L.P. | 10% Owner | A Award deriv | 2023-03-20 | 2023-10-10 | 2,672 | — | $0 | 2,672 | SEC↗ |
| Sanderling Ventures VII, L.P. | 10% Owner | A Award deriv | 2023-03-20 | 2023-10-10 | 16,539 | — | $0 | 16,539 | SEC↗ |
| Sanderling Ventures VII, L.P. | 10% Owner | A Award deriv | 2023-03-20 | 2023-10-10 | 2,685 | — | $0 | 2,685 | SEC↗ |
| Sanderling Ventures VII, L.P. | 10% Owner | A Award deriv | 2023-03-20 | 2023-10-10 | 1,910 | — | $0 | 1,910 | SEC↗ |
| Sanderling Ventures VII, L.P. | 10% Owner | A Award deriv | 2023-03-20 | 2023-10-10 | 6,852 | — | $0 | 6,852 | SEC↗ |
| Sanderling Ventures VII, L.P. | 10% Owner | A Award deriv | 2023-03-20 | 2023-10-10 | 15,403 | — | $0 | 15,403 | SEC↗ |
| Sanderling Ventures VII, L.P. | 10% Owner | A Award deriv | 2023-03-20 | 2023-10-10 | 183 | — | $0 | 183 | SEC↗ |
| Sanderling Ventures VII, L.P. | 10% Owner | A Award deriv | 2023-03-20 | 2023-10-10 | 237 | — | $0 | 237 | SEC↗ |
| Sanderling Ventures VII, L.P. | 10% Owner | A Award | 2023-03-20 | 2023-10-10 | 14,425 | — | $0 | 14,425 | SEC↗ |
| Sanderling Ventures VII, L.P. | 10% Owner | A Award | 2023-03-20 | 2023-10-10 | 703,388 | — | $0 | 703,388 | SEC↗ |